+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Mouse models of PIK3CA mutations: one mutation initiates heterogeneous mammary tumors



Mouse models of PIK3CA mutations: one mutation initiates heterogeneous mammary tumors



Febs Journal 280(12): 2758-2765



The phosphoinositide 3-kinase (PI3K) signaling pathway is crucial for cell growth, proliferation, metabolism, and survival, and is frequently deregulated in human cancer, including ~ 70% of breast tumors. PIK3CA, the gene encoding the catalytic subunit p110α of PI3K, is mutated in ~ 30% of breast cancers. However, the exact mechanism of PIK3CA-evoked breast tumorigenesis has not yet been defined. Genetically engineered mouse models are valuable for examining the initiation, development and progression of cancer. Transgenic mice harboring hotspot mutations in p110α have helped to elucidate breast cancer pathogenesis and increase our knowledge about molecular and cellular alterations in vivo. They are also useful for the development of therapeutic strategies. Here, we describe current mouse models of mutant PIK3CA in the mammary gland, and discuss differences in tumor latency and pathogenesis.

(PDF emailed within 0-6 h: $19.90)

Accession: 036755804

Download citation: RISBibTeXText

PMID: 23384338

DOI: 10.1111/febs.12175


Related references

Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors. Plos One 7(5): E36924, 2012

Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors. Cancer Research 71(13): 4344-4351, 2011

Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation. Cancer Research 71(7): 2706-2717, 2011

Common and distinct features of mammary tumors driven by Pten-deletion or activating Pik3ca mutation. Oncotarget 7(8): 9060-9068, 2016

PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene. Advances in Clinical and Experimental Medicine 27(7): 963-969, 2018

Mouse Models for Exploring the Biological Consequences and Clinical Significance of PIK3CA Mutations. Biomolecules 9(4), 2019

Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models. Proceedings of the National Academy of Sciences of the United States of America 103(46): 17396-17401, 2006

Genes affected by mouse mammary tumor virus (MMTV) proviral insertions in mouse mammary tumors are deregulated or mutated in primary human mammary tumors. Oncotarget 3(11): 1320-1334, 2013

KRAS and PIK3CA mutation frequencies in patient-derived xenograft models of pancreatic and colorectal cancer are reflective of patient tumors and stable across passages. American Surgeon 80(9): 873-877, 2014

Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors. Cancer Research 48(20): 5747-5753, 1988

Therapeutic perturbation of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors. Cancer Research 49(14): 3747-3753, 1989

PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. Cancer Research 66(15): 7401-7404, 2006

Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes. Gastroenterology 151(3): 440-447.E1, 2017

FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features. Plos One 7(2): E30801, 2012

Genomic instability in mouse mammary tumors with p53 deficiency or mutation. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 542, 1995